G. Berger

1.0k total citations
39 papers, 727 citations indexed

About

G. Berger is a scholar working on Pulmonary and Respiratory Medicine, Hepatology and Oncology. According to data from OpenAlex, G. Berger has authored 39 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Hepatology and 9 papers in Oncology. Recurrent topics in G. Berger's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Nanoparticle-Based Drug Delivery (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). G. Berger is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Nanoparticle-Based Drug Delivery (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). G. Berger collaborates with scholars based in Germany, United States and Austria. G. Berger's co-authors include U. Pohlen, Hans Scherübl, Hans‐Dieter Foss, Patricia Grabowski, H. J. Buhr, Claudia Spies, Ulrich Mansmann, Hans Rommelspacher, L. Hannemann and Christian Marks and has published in prestigious journals such as Radiology, Annals of the New York Academy of Sciences and International Journal of Cancer.

In The Last Decade

G. Berger

37 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Berger Germany 15 196 181 180 142 119 39 727
Jacques Ropers France 15 195 1.0× 257 1.4× 152 0.8× 153 1.1× 335 2.8× 31 1.0k
Toshiki Hirata Japan 21 293 1.5× 102 0.6× 74 0.4× 348 2.5× 336 2.8× 43 1.1k
Minoru Kobayashi Japan 14 104 0.5× 157 0.9× 33 0.2× 159 1.1× 111 0.9× 69 625
Johann Pidlich Austria 16 195 1.0× 416 2.3× 75 0.4× 88 0.6× 216 1.8× 29 1.0k
V. V. Moroz Russia 15 122 0.6× 110 0.6× 207 1.1× 253 1.8× 121 1.0× 91 746
Hans Jørgen Frederiksen Denmark 12 81 0.4× 61 0.3× 72 0.4× 82 0.6× 226 1.9× 25 489
Jung Hoon Kim South Korea 16 338 1.7× 57 0.3× 43 0.2× 180 1.3× 100 0.8× 35 737
William J. Schirmer United States 18 615 3.1× 604 3.3× 373 2.1× 117 0.8× 244 2.1× 33 1.1k
Laure-Anne Teuwen Belgium 9 178 0.9× 76 0.4× 341 1.9× 118 0.8× 77 0.6× 25 1.1k

Countries citing papers authored by G. Berger

Since Specialization
Citations

This map shows the geographic impact of G. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Berger more than expected).

Fields of papers citing papers by G. Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Berger. The network helps show where G. Berger may publish in the future.

Co-authorship network of co-authors of G. Berger

This figure shows the co-authorship network connecting the top 25 collaborators of G. Berger. A scholar is included among the top collaborators of G. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Berger. G. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pohlen, U., H. J. Buhr, G. Berger, Jörg‐Peter Ritz, & Christoph Holmer. (2011). Hepatic arterial infusion (HAI) with PEGylated liposomes containing 5-FU improves tumor control of liver metastases in a rat model. Investigational New Drugs. 30(3). 927–935. 11 indexed citations
2.
Berger, G., et al.. (2008). 3 D-Rekonstruktion intrakranieller Gefäße mit Hilfe des Colour-Doppler-Energy (CDE)-Verfahrens - Erste Versuche. Ultraschall in der Medizin - European Journal of Ultrasound. 17(6). 277–280.
3.
Widder, Bernhard, G. Berger, K. Paulat, et al.. (2008). Reproduzierbarkeit sonographischer Kriterien zur Charakterisierung von Karotisstenosen. Ultraschall in der Medizin - European Journal of Ultrasound. 11(2). 56–61. 3 indexed citations
4.
Dossow, Vera von, et al.. (2007). Propofol Increased the Interleukin-6 to Interleukin-10 Ratio more than Isoflurane after Surgery in Long-term Alcoholic Patients. Journal of International Medical Research. 35(3). 395–405. 22 indexed citations
5.
Schiffmann, Lars M., et al.. (2005). Colon perforation in an adolescent after short‐term diclofenac intake. ANZ Journal of Surgery. 75(8). 726–727. 14 indexed citations
6.
7.
Schiffmann, Leif, et al.. (2004). Colon perforation with acute peritonitis after taking clindamycin and diclofenac following wisdom tooth removal. Journal of Cranio-Maxillofacial Surgery. 32(5). 330–334. 17 indexed citations
8.
9.
Grabowski, Patricia, Gudrun Ahnert‐Hilger, Hans‐Dieter Foss, et al.. (2004). Heterogeneous Expression of Neuroendocrine Marker Proteins in Human Undifferentiated Carcinoma of the Colon and Rectum. Annals of the New York Academy of Sciences. 1014(1). 270–274. 24 indexed citations
10.
Grabowski, Patricia, Ioannis Anagnostopoulos, Hans‐Dieter Foss, et al.. (2001). Neuroendocrine differentiation is a relevant prognostic factor in stage III–IV colorectal cancer. European Journal of Gastroenterology & Hepatology. 13(4). 405–411. 66 indexed citations
11.
Pohlen, U., et al.. (2001). Improved Tumor Targeting by Regional Carboplatin Application Combined with Gelfoam<sup>®</sup>. Chemotherapy. 47(2). 143–149. 2 indexed citations
12.
Bolder, Ulrich, et al.. (2000). Long‐Term Risk of Gastrointestinal Tumor Recurrence After Postoperative Treatment with Recombinant Human Growth Hormone. Journal of Parenteral and Enteral Nutrition. 24(3). 140–144. 19 indexed citations
13.
Grabowski, Patricia, Benno Mann, Ulrich Mansmann, et al.. (2000). Expression of SIALYL‐Lex antigen defined by MAb AM‐3 is an independent prognostic marker in colorectal carcinoma patients. International Journal of Cancer. 88(2). 281–286. 3 indexed citations
14.
15.
Pohlen, U., A. J. Kroesen, G. Berger, & H. J. Buhr. (1999). Diagnostics and surgical treatment strategy for rectal cavernous hemangiomas based on three case examples. International Journal of Colorectal Disease. 14(6). 300–303. 10 indexed citations
16.
Spies, Claudia, Christian Müller, Christian Marks, et al.. (1998). β‐Carbolines in alcohol‐dependent intensive care patients during prophylactics and therapy of alcohol withdrawal syndrome. Addiction Biology. 3(3). 281–294. 7 indexed citations
17.
Berger, G., et al.. (1997). Simultaneous determination of 5-fluorouracil and its active metabolites in serum and tissue by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 702(1-2). 193–202. 23 indexed citations
18.
Spies, Claudia, Alain Nordmann, Christian Marks, et al.. (1996). Intensive care unit stay is prolonged in chronic alcoholic men following tumor resection of the upper digestive tract. Acta Anaesthesiologica Scandinavica. 40(6). 649–656. 128 indexed citations
19.
Spies, Claudia, Hans Rommelspacher, Christian Müller, et al.. (1996). β‐Carbolines in chronic alcoholics following trauma. Addiction Biology. 1(1). 93–103. 12 indexed citations
20.
Spies, Claudia, Hans Rommelspacher, Christian Müller, et al.. (1995). β‐Carbolines in Chronic Alcoholics Undergoing Elective Tumor Resection. Alcoholism Clinical and Experimental Research. 19(4). 969–976. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques Ropers Breakdown of academic impact, for papers by Toshiki Hirata Breakdown of academic impact, for papers by Minoru Kobayashi Breakdown of academic impact, for papers by Johann Pidlich Breakdown of academic impact, for papers by V. V. Moroz Breakdown of academic impact, for papers by Hans Jørgen Frederiksen Breakdown of academic impact, for papers by Jung Hoon Kim Breakdown of academic impact, for papers by William J. Schirmer Breakdown of academic impact, for papers by Laure-Anne Teuwen
Rankless by CCL
2026